The field of immunogerontology investigates age-associated declines in immune function, particularly focusing on the reduced lymphoid potential of ...

Newly updated research shows incredible promise, but it's still just the beginning of the era of real cancer therapies.

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Dr. David Liu, pictured with former lab members Holly Rees ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...

Hundreds of millions of people worldwide are affected by genetic diseases that modern medicine struggles to cure. Many of these conditions stem not from mutations but from gene silencing, where ...

In today’s installment of “hey please don’t do that,” the Wall Street Journal reports that a clandestine startup named Preventive is trying to usher in the first known birth of a genetically-modified ...

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...

In a step toward the wider use of gene editing, a treatment that uses Crispr successfully slashed high cholesterol levels in a small number of people. In a trial conducted by Swiss biotech company ...

Please provide your email address to receive an email when new articles are posted on . A gene-editing therapy targeting ANGPTL3 did not cause serious adverse events in an early study. Higher doses of ...